Napsin A – MMab

SKU: 59f421483de3 Categories: , , ,

Ihc Of Napsin A On An Ffpe Lung Carcinoma Tissue

IHC of Napsin A on a FFPE Lung Carcinoma Tissue

Specification Sheets
Safety Data Sheet
Intended UseFor In Vitro Diagnostic Use
Summary and Explanation

The activation peptides of aspartic proteinases play a role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional glycosylated aspartic proteinase precursor containg an RGD motif and an addition 18 residues at its C-terminus.

In normal tissue, anti-Napsin A labels type II pneumocytes in adult lung and epithelial cells in kidney tissues. In abnormal tissues, Napsin A is a useful marker for lung adenocarcinoma.

Antibody TypeMouse MonoclonalCloneBSB-112
IsotypeIgG1/KReactivityParaffin, Frozen
LocalizationCytoplasmicControlKidney, Lung, Renal Cell Carcinoma, Lung Carcinoma
PresentationNapsin A is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.
Catalog No.Antibody TypeDilutionVolume/QTY
BSB 3392PredilutedReady-To-Use3.0 ml
BSB 3393PredilutedReady-To-Use7.0 ml
BSB 3394PredilutedReady-To-Use15.0 ml
BSB 3395Concentrated1:50-1:2000.1 ml
BSB 3396Concentrated1:50-1:2000.5 ml
BSB 3397Concentrated1:50-1:2001.0 ml
BSB 3398Control Slides5
Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.

Related products

Skip to content